CRYOPORT, INC. Financing Cash Flow
CRYOPORT, INC. (CYRX) reported Financing Cash Flow of $738.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- CRYOPORT, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $653.00K.
- CRYOPORT, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $85.00K.
- CRYOPORT, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$2.15M, a 207.01% decline year-over-year.
- CRYOPORT, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$2.87M.
- CRYOPORT, INC. net cash provided by (used in) financing activities for fiscal 2025 was -$21.07M.
- CRYOPORT, INC. net cash provided by (used in) financing activities for fiscal 2024 was -$161.53M.
- CRYOPORT, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$23.80M.
- CRYOPORT, INC. net cash provided by (used in) financing activities for fiscal 2022 was -$39.17M, a 106.94% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $653.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $738.00K 10-Q · filed 2026-08-06 | -$1.42M derived: sum of 3 quarters · filed 2026-08-06 | -$4.28M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $85.00K 10-Q · filed 2026-05-05 | -$2.07M derived: sum of 2 quarters · filed 2026-05-05 | -$4.94M derived: sum of 3 quarters · filed 2026-05-05 | -$20.80M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$5.02M derived: sum of 2 quarters · filed 2026-03-05 | -$20.89M derived: sum of 3 quarters · filed 2026-08-06 | -$21.07M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | -$2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$18.73M derived: sum of 2 quarters · filed 2026-08-06 | -$18.92M 10-Q · filed 2025-11-06 | -$16.91M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | -$15.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$16.05M 10-Q · filed 2026-08-06 | -$14.04M derived: sum of 3 quarters · filed 2026-08-06 | -$169.33M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$189.00K 10-Q · filed 2026-05-05 | $1.82M derived: sum of 2 quarters · filed 2026-05-05 | -$153.47M derived: sum of 3 quarters · filed 2026-05-05 | -$162.23M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$153.28M derived: sum of 2 quarters · filed 2026-03-05 | -$162.04M derived: sum of 3 quarters · filed 2026-03-05 | -$161.53M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | -$155.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$164.06M derived: sum of 2 quarters · filed 2025-11-06 | -$163.54M 10-Q · filed 2025-11-06 | -$163.67M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | -$8.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$8.25M 10-Q · filed 2025-08-12 | -$8.38M derived: sum of 3 quarters · filed 2026-03-05 | -$33.27M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | $512.00K 10-Q · filed 2025-05-08 | $386.00K derived: sum of 2 quarters · filed 2026-03-05 | -$24.50M derived: sum of 3 quarters · filed 2026-03-05 | -$23.36M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | -$126.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$25.02M derived: sum of 2 quarters · filed 2026-03-05 | -$23.87M derived: sum of 3 quarters · filed 2026-03-05 | -$23.80M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | -$24.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$23.74M derived: sum of 2 quarters · filed 2024-11-07 | -$23.67M 10-Q · filed 2024-11-07 | -$28.98M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | $1.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.22M 10-Q · filed 2024-08-08 | -$4.09M derived: sum of 3 quarters · filed 2025-03-07 | -$4.55M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-03-31 | $71.00K 10-Q · filed 2024-05-08 | -$5.24M derived: sum of 2 quarters · filed 2025-03-07 | -$5.69M derived: sum of 3 quarters · filed 2025-03-07 | -$31.05M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | -$5.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$5.76M derived: sum of 2 quarters · filed 2025-03-07 | -$31.13M derived: sum of 3 quarters · filed 2025-03-07 | -$39.17M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | -$459.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$25.82M derived: sum of 2 quarters · filed 2023-11-09 | -$33.87M 10-Q · filed 2023-11-09 | $254.71M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | -$25.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$33.41M 10-Q · filed 2023-08-09 | $255.17M derived: sum of 3 quarters · filed 2024-03-13 | $257.66M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-03-31 | -$8.05M 10-Q · filed 2023-05-04 | $280.53M derived: sum of 2 quarters · filed 2024-03-13 | $283.02M derived: sum of 3 quarters · filed 2024-03-13 | $284.90M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $288.57M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $291.07M derived: sum of 2 quarters · filed 2024-03-13 | $292.95M derived: sum of 3 quarters · filed 2024-03-13 | $564.34M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $4.37M derived: sum of 2 quarters · filed 2022-11-04 | $275.77M 10-Q · filed 2022-11-04 | $542.21M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $273.28M 10-Q · filed 2022-08-04 | $539.72M derived: sum of 3 quarters · filed 2023-02-28 | $541.87M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $271.39M 10-Q · filed 2022-05-05 | $537.84M derived: sum of 2 quarters · filed 2023-02-28 | $539.99M derived: sum of 3 quarters · filed 2023-02-28 | $654.11M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $266.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $268.59M derived: sum of 2 quarters · filed 2023-02-28 | $382.72M derived: sum of 3 quarters · filed 2023-02-28 | $385.58M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $2.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $116.28M derived: sum of 2 quarters · filed 2021-11-04 | $119.14M 10-Q · filed 2021-11-04 | $119.14M 10-Q · filed 2020-11-06 | $120.24M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | $114.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $116.99M 10-Q · filed 2021-08-06 | $116.99M 10-Q · filed 2020-08-10 | $118.08M derived: sum of 3 quarters · filed 2022-02-28 | $119.49M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $2.86M 10-Q · filed 2021-05-06 | $2.86M 10-Q · filed 2020-05-08 | $3.96M derived: sum of 2 quarters · filed 2022-02-28 | $5.37M derived: sum of 3 quarters · filed 2022-02-28 | $75.72M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $2.50M derived: sum of 2 quarters · filed 2022-02-28 | $72.86M derived: sum of 3 quarters · filed 2022-02-28 | $74.15M 10-K · filed 2022-02-28 | $74.15M 10-K · filed 2020-03-10 | |||
| 2019-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $71.77M derived: sum of 2 quarters · filed 2020-11-06 | $73.06M 10-Q · filed 2020-11-06 | $97.99M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $70.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $71.65M 10-Q · filed 2020-08-10 | $96.58M derived: sum of 3 quarters · filed 2020-08-10 | $101.88M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $1.29M 10-Q · filed 2020-05-08 | $26.23M derived: sum of 2 quarters · filed 2020-05-08 | $31.53M derived: sum of 3 quarters · filed 2020-05-08 | $34.52M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $24.94M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | $30.24M derived: sum of 2 quarters · filed 2020-03-10 | $33.23M derived: sum of 3 quarters · filed 2020-03-10 | $38.53M 10-K · filed 2020-03-10 | ||||
| 2018-09-30 | $5.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $8.29M derived: sum of 2 quarters · filed 2019-11-12 | $13.60M 10-Q · filed 2019-11-12 | $14.98M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $8.29M 10-Q · filed 2019-08-09 | $9.68M derived: sum of 3 quarters · filed 2019-08-09 | $13.42M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $5.30M 10-Q · filed 2019-05-09 | $6.68M derived: sum of 2 quarters · filed 2019-05-09 | $10.43M derived: sum of 3 quarters · filed 2019-05-09 | $9.72M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $5.13M derived: sum of 2 quarters · filed 2019-03-13 | $4.42M derived: sum of 3 quarters · filed 2019-03-13 | $15.90M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.04M derived: sum of 2 quarters · filed 2018-11-08 | $14.52M 10-Q · filed 2018-11-08 | $17.65M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | -$704.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $10.78M 10-Q · filed 2018-08-09 | $13.90M derived: sum of 3 quarters · filed 2018-08-09 | |||||
| 2017-03-31 | $11.48M 10-Q · filed 2018-05-03 | $14.61M derived: sum of 2 quarters · filed 2018-05-03 | ||||||
| 2016-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $6.14M 10-K · filed 2018-03-08 | $6.06M 10-K · filed 2018-03-08 | |||||
| 2016-09-30 | $2.94M 10-Q · filed 2017-11-02 | |||||||
| 2013-12-31 | $531.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | $1.99M derived: sum of 2 quarters · filed 2014-02-13 | $2.96M 10-Q · filed 2014-02-13 | $4.15M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2013-09-30 | $1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | $2.42M 10-Q · filed 2013-11-18 | $3.62M derived: sum of 3 quarters · filed 2013-11-18 | $3.58M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2013-06-30 | $966.68K 10-Q · filed 2013-08-14 | $2.16M derived: sum of 2 quarters · filed 2013-08-14 | $2.12M derived: sum of 3 quarters · filed 2014-02-13 | $2.05M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2013-03-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $1.15M derived: sum of 2 quarters · filed 2014-02-13 | $1.09M derived: sum of 3 quarters · filed 2014-02-13 | $909.39K 10-K · filed 2013-06-25 | ||||
| 2012-12-31 | -$37.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-13 | -$105.80K derived: sum of 2 quarters · filed 2014-02-13 | -$283.07K 10-Q · filed 2014-02-13 | $3.66M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-09-30 | -$67.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-18 | -$245.25K 10-Q · filed 2013-11-18 | $3.70M derived: sum of 3 quarters · filed 2013-11-18 | $3.19M derived: sum of 4 quarters · filed 2013-11-18 | ||||
| 2012-06-30 | -$177.28K 10-Q · filed 2013-08-14 | $3.77M derived: sum of 2 quarters · filed 2013-08-14 | $3.26M derived: sum of 3 quarters · filed 2013-08-14 | $2.94M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-25 | $3.44M derived: sum of 2 quarters · filed 2013-06-25 | $3.11M derived: sum of 3 quarters · filed 2013-06-25 | $2.51M 10-K · filed 2013-06-25 | ||||
| 2011-12-31 | -$508.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-14 | -$834.42K derived: sum of 2 quarters · filed 2013-02-14 | -$1.44M 10-Q · filed 2013-02-14 | $6.37M derived: sum of 4 quarters · filed 2013-02-14 | ||||
| 2011-09-30 | -$325.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-09 | -$931.32K 10-Q · filed 2012-11-09 | $6.88M derived: sum of 3 quarters · filed 2012-11-09 | $7.30M derived: sum of 4 quarters · filed 2012-11-09 | ||||
| 2011-06-30 | -$605.40K 10-Q · filed 2012-08-14 | $7.21M derived: sum of 2 quarters · filed 2012-08-14 | $7.63M derived: sum of 3 quarters · filed 2012-08-14 | $10.35M derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | $7.81M derived: 10-K 12 month − 10-Q 9 month · filed 2012-06-27 | $8.23M derived: sum of 2 quarters · filed 2012-06-27 | $10.96M derived: sum of 3 quarters · filed 2012-06-27 | $10.93M 10-K · filed 2012-06-27 | ||||
| 2010-12-31 | $421.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-21 | $3.14M derived: sum of 2 quarters · filed 2012-02-21 | $3.11M 10-Q · filed 2012-02-21 | |||||
| 2010-09-30 | $2.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-14 | $2.69M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$30.00K 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |